Trial Profile
Microvascular Coronary Disease In Women: Impact Of Ranolazine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris; Myocardial ischaemia
- Focus Therapeutic Use
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jan 2009 Planned end date changed from 1 Jun 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.